What is the treatment for ringworm (tinea infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ringworm (Tinea Infection)

Topical antifungal agents are the first-line treatment for tinea corporis (ringworm) and are generally effective for localized infections. 1

First-Line Treatment

Topical Antifungal Therapy

  • Apply topical antifungal medication to affected areas and 2 cm beyond the border of the lesion 1
  • Continue treatment for at least one week after clinical clearing of infection 2
  • Effective topical agents include:
    • Azoles: clotrimazole 1%, miconazole 2% - apply twice daily for 2-4 weeks 1, 2
    • Allylamines: terbinafine 1%, naftifine 1% - apply once or twice daily for 1-2 weeks 1
  • Allylamines may require fewer applications and shorter treatment duration compared to azoles 1
  • Pooled data shows both terbinafine and naftifine are effective with low rates of adverse effects 1

When to Consider Oral Therapy

Oral antifungal therapy should be considered in the following situations:

  • Extensive or widespread tinea corporis 3
  • Infection adjacent to eyes, ears, or mouth where topical application is difficult 3
  • Infection involving complex skin folds 3
  • Failure of topical therapy 3, 4

Oral Antifungal Options

  • Griseofulvin:
    • Adults: 500 mg daily for 2-4 weeks 5
    • Children: 10 mg/kg daily for 2-4 weeks 5
    • FDA-approved for tinea corporis 5
  • Terbinafine:
    • Adults: 250 mg daily for 1-2 weeks 4
    • Children: dosing based on weight (62.5-250 mg daily) for 2-4 weeks 6
  • Fluconazole:
    • 50-100 mg daily or 150 mg once weekly for 2-3 weeks 4
  • Itraconazole:
    • 100 mg daily for 2 weeks or 200 mg daily for 7 days 4

Special Considerations

Inflammatory Lesions

  • For lesions with significant inflammation, consider:
    • Topical agents with inherent anti-inflammatory properties 2
    • In severe cases, short-term use of combination antifungal/steroid agents may be beneficial, but use with caution due to potential for skin atrophy 2

Prevention and Control

  • General hygiene measures should be observed to control sources of infection or reinfection 5, 7
  • Cleanse personal items like combs and brushes with disinfectant 7
  • Consider screening family members, especially for highly contagious infections 7

Treatment Duration and Follow-up

  • Treatment should continue until the infecting organism is completely eradicated 5
  • For tinea corporis, typical treatment duration is 2-4 weeks for topical therapy 5, 2
  • Continue treatment for at least one week after clinical clearing 2
  • Clinical relapse will occur if medication is not continued until the infection is eradicated 5

Common Pitfalls

  • Failure to accurately diagnose the infection before starting treatment 5
  • Discontinuing treatment too early (before complete eradication) 5
  • Not treating a wide enough area around the visible lesion 1
  • Neglecting to address potential sources of reinfection 7, 5
  • Using topical steroids alone without antifungal agents, which can worsen the infection ("tinea incognito") 2

References

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Tinea Corporis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.